A Phase 2 Trial to Evaluate the Early Bactericidal Activity and Safety of Meropenem With Amoxicillin/Clavulanate Plus Either Pyrazinamde or Bedaquiline in Adults With Newly Diagnosed Rifampicin-susceptible Pulmonary Tuberculosis
Latest Information Update: 28 Jan 2022
At a glance
- Drugs Amoxicillin/clavulanic acid (Primary) ; Bedaquiline (Primary) ; Meropenem (Primary) ; Pyrazinamide (Primary) ; Rifampicin/isoniazid/pyrazinamide/ethambutol
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- Acronyms TB_COMBO_01
- 24 Jan 2022 Status changed from recruiting to completed.
- 20 Nov 2020 New trial record